Targeting the IL-15/CD122 signaling pathway: reversing TRM cell-mediated immune memory in vitiligo
Vitiligo is a chronic autoimmune disorder in which melanocyte−specific CD8+ T cells destroy pigment−forming cells, producing persistent depigmented macules. Recurrence after treatment implicates tissue−resident memory T (TRM) cells that are maintained by interleukin−15 (IL−15) signaling. Here we rev...
Saved in:
| Main Authors: | Xiangxi Su, Fang Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1639732/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of oral upadacitinib-topical ruxolitinib combination therapy in the treatment of progressive nonsegmental vitiligo
by: Weiran Li, MD, et al.
Published: (2025-10-01) -
Cytokine dynamics in vitiligo: the roles of interleukin-10 and interleukin-17
by: Hanan Mohammed Saied
Published: (2025-08-01) -
Study of the Immunological Status of Iraqi Vitiligo Patients
by: Baghdad Science Journal
Published: (2016-09-01) -
Descriptive Analysis of Reported Adverse Events Associated with Vitiligo Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013–2023
by: Saleh F. Alqifari, et al.
Published: (2025-07-01) -
Managing Insecticide and Miticide Resistance in Florida Landscapes
by: Eileen A. Buss, et al.
Published: (2007-10-01)